Delete the principle of "discretion" in naming traditional Chinese Medicine

The difference between "daochisan" and "daochisan" is different in efficacy; the compound preparation of Chinese and Western medicine was banned in foreign countries for a long time, and continued to have "efficacy myth" under the cover of domestic traditional Chinese medicine Yao Zhibin, member of the National Committee of the Chinese people's Political Consultative Conference (CPPCC) and chairman of the Jiusan Society of Sichuan Province, will submit a proposal to standardize the names of traditional Chinese medicines and phase out proprietary Chinese medicines containing western medicine ingredients, reporters learned yesterday Yao Zhibin, a consumer who is easily misled by the nonstandard naming of traditional Chinese medicine, said that China has a unique generic name for the use of Western medicine, and forbids the use of medicine names that may indicate curative effect, but the traditional Chinese medicine and Chinese patent medicine are subject to "discretionary treatment", which is easy to mislead consumers Such as Xianlinggubao capsule, Feilong lethal pill, secret Shugan pill, etc Yao Zhibin said that there are many phenomena of the same name different drugs and the same medicine different names in traditional Chinese medicine, disturbing the market and affecting the use of traditional Chinese medicine Some names of Chinese patent medicines with different effects are very similar, such as daochisan and daochisan, feiersan and feierwan, huadusan and huadusan, zhibaoding and zhibaodan, etc There is only one word difference, but there is difference in efficacy In addition, "more than one drug" is also easy to cause prescription errors and increase the burden of patients Suggestion: Yao Zhibin, a Chinese patent medicine with western medicine ingredients, also mentioned that the mixture of Chinese and Western medicine is popular in the name of traditional Chinese medicine, which seriously hinders the healthy development of traditional Chinese medicine industry Chinese and western compound preparations are classified as traditional Chinese medicine when they are submitted for approval, so they enjoy the same "privilege" as traditional Chinese medicine in naming, which leads to unclear expression of drug names, and it is difficult for ordinary people to understand their ingredients through names Chinese and Western medicine compound preparation was banned in foreign countries, but in China, under the cover of traditional Chinese medicine, it continues to have "efficacy myth" Yao Zhibin suggested that during the 3-5-year transition period, the state should organize experts to sort out the generic names of all Chinese patent medicines and name them in a unified and standardized way, and no longer approve the varieties of Chinese patent medicines with western medicine ingredients, and gradually eliminate the approved varieties of Chinese patent medicines with Western Medicine ingredients within the 5-year period.